Article
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
Journal of Alzheimer's disease : JAD - 1 Jan 2014
Cheng David, Spiro Adena S, Jenner Andrew M, Garner Brett, Karl Tim
Abstract excerpt
Impairments in cognitive ability and widespread pathophysiological changes caused by neurotoxicity, neuroinflammation, oxidative damage, and altered cholesterol homeostasis are associated with Alzheimer's disease (AD). Cannabidiol (CBD) has been shown to reverse cognitive deficits of AD transgenic mice and to exert neuroprotective, anti-oxidative, and anti-inflammatory properties in vitro and in vivo. Here we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
